Featured Products

About Izun

Izun Pharmaceuticals Corp. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments.

Recent News

  • Izun CEO, Dr. William Levine, speaks at Dutch Periodontal Society annual meeting Dr William Levine, founder and CEO of Izun Pharmaceuticals, was the featured speaker at the annual meeting of the Dutch Periodontal Society. The meeting, which took place outside of Amsterdam in November 2013, was attended by the overwhelming majority of all periodontists in Holland. Dr. Levine introduced new treatment paradigms for controlling periodontal inflammation and
    February 13, 2014 plus
  • Izun Pharmaceuticals Corporation Announces a Development Project with Ducere Pharma LLC Izun Pharmaceuticals Corporation, an emerging pharmaceutical company which focuses on developing high efficacy botanical pharmaceutical products, announced a strategic alliance for the US and Canadian markets with Ducere Pharma LLC, a privately owned healthcare company that markets innovative consumer healthcare products under well recognized brand names. The alliance will combine Izun’s patented and patent pending
    December 19, 2013 plus

We would love to be in touch with you

  • This field is for validation purposes and should be left unchanged.